Rhythm Pharmaceuticals reported cash from operations of -$9.15M and free cash flow of -$9.15M for the quarter ended Jun 2026, up 60.7% year over year. This cash flow statement covers 40 quarters of results from Sep 2016 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||||||||||||||||
| Net Income | -35.11M | -50.85M | -52.53M | -44.87M | -40.86M | -42.49M | -52.18M | -46.70M | -44.16M | -41.63M | -141.37M | -32.28M | -43.64M | -43.29M | -49.52M | -46.63M | -52.90M | -47.51M | -55.64M | -49.30M | ||||||||||||||||||||
| Share-based CompensationStock Comp. | 0.96M | 4.68M | 4.61M | 1.40M | 1.37M | 5.29M | 6.38M | 1.34M | 1.32M | 8.67M | 7.77M | 3.12M | 3.12M | 10.56M | 12.86M | 3.12M | 3.12M | 19.27M | 23.10M | 26.06M | ||||||||||||||||||||
| Deferred Taxes | -8.99M | |||||||||||||||||||||||||||||||||||||||
| Cash from OperationsCash from Ops. | -40.16M | -40.47M | -53.63M | -38.81M | -46.99M | -34.00M | -36.43M | -41.09M | -29.25M | -29.38M | -40.74M | -29.08M | -25.21M | -18.84M | -40.35M | -23.31M | -26.62M | -25.39M | -44.19M | -9.15M | ||||||||||||||||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||||||||||||||||
| Amortization of Deferred ChargesAmort. Deferred Charges | 2.14M | 3.20M | 3.06M | 3.13M | 3.15M | 4.02M | 4.01M | |||||||||||||||||||||||||||||||||
| Depreciation & Amortization (CF)Dep. & Amort. | 0.32M | |||||||||||||||||||||||||||||||||||||||
| Change in Working Capital | ||||||||||||||||||||||||||||||||||||||||
| Change in ReceivablesChange Receivables | 0.60M | 2.90M | 1.89M | 5.71M | 0.71M | 0.33M | -0.17M | 2.90M | 1.71M | -0.79M | -0.69M | 7.83M | 6.60M | -6.17M | 8.11M | 6.22M | ||||||||||||||||||||||||
| Change in InventoryChange Inventory | -0.01M | 1.23M | 2.57M | 0.69M | 1.58M | 0.86M | -0.12M | 3.49M | 1.90M | 4.85M | 0.57M | -0.48M | 2.45M | 4.93M | 3.09M | 2.34M | ||||||||||||||||||||||||
| Change in Account PayablesChange Payables | ||||||||||||||||||||||||||||||||||||||||
| Change in Accured ExpensesChange Accured Exp. | 5.99M | 12.92M | -0.05M | -1.55M | -12.57M | 15.71M | 5.17M | 0.66M | 4.09M | 4.86M | -1.25M | 0.48M | 7.51M | 15.18M | -3.63M | 13.26M | 11.02M | 1.25M | -5.62M | 16.46M | ||||||||||||||||||||
| Investing Activities | ||||||||||||||||||||||||||||||||||||||||
| Capital ExpendituresCapex | 10.27M | 1.28M | 6.66M | -2.69M | 0.87M | -0.00M | 0.10M | -1.22M | -0.54M | 0.00M | -1.20M | -1.05M | -0.91M | -4.79M | -0.10M | -5.42M | 5.24M | 1.24M | -0.43M | |||||||||||||||||||||
| Change in Acquisitions & DivestmentsChange Acquisitions | 156.66M | 69.05M | 112.13M | 51.00M | 61.48M | 59.64M | 92.67M | 124.50M | 74.50M | 63.29M | 70.05M | 57.75M | 45.30M | 87.53M | 58.33M | 80.99M | 61.50M | 51.65M | 99.25M | 57.50M | ||||||||||||||||||||
| Cash from Investing ActivitiesCash from Investing | 62.78M | 7.25M | 72.52M | 35.98M | -39.70M | -40.77M | 18.46M | 48.19M | -94.96M | 22.64M | 30.05M | -8.56M | -90.82M | 21.16M | 24.81M | 54.03M | -246.35M | 30.35M | 57.05M | 14.01M | ||||||||||||||||||||
| Financing Activities | ||||||||||||||||||||||||||||||||||||||||
| Other financing activitiesOther financing | 0.18M | 0.10M | 0.40M | 3.46M | 5.89M | 0.67M | 0.23M | 1.58M | 5.00M | 6.35M | 2.55M | 4.09M | 2.99M | 2.23M | 3.44M | 5.49M | 177.50M | 6.09M | 7.00M | |||||||||||||||||||||
| Cash from Financing ActivitiesCash from Financing | 0.41M | 0.10M | 0.40M | 37.50M | 158.56M | 17.36M | -0.13M | -0.96M | 73.04M | 2.42M | 4.24M | 146.18M | 2.49M | 38.33M | 32.50M | -0.89M | 189.30M | -2.95M | -5.40M | -1.17M | ||||||||||||||||||||
| Change in Capital Stock | ||||||||||||||||||||||||||||||||||||||||
| Net Shares Issued and RepurchasedNet Shares Issued | 1.68M | 2.28M | 1.05M | 0.98M | ||||||||||||||||||||||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | -0.01M | 14.14M | 34.03M | 154.62M | -154.62M | |||||||||||||||||||||||||||||||||||
| Additional items | ||||||||||||||||||||||||||||||||||||||||
| Exchange Rate EffectFX Effect | 0.09M | -0.11M | 0.08M | -0.19M | -0.07M | -0.30M | -0.60M | 0.98M | -0.00M | -0.28M | 0.30M | 0.06M | 0.45M | -0.22M | ||||||||||||||||||||||||||
| Change in Cash | 23.03M | -33.12M | 19.29M | 34.67M | 71.88M | -57.41M | -18.02M | 6.02M | -51.09M | -4.51M | -6.52M | 108.24M | -114.14M | 41.62M | 16.96M | 29.55M | -83.36M | 2.07M | 7.92M | 3.48M | ||||||||||||||||||||
| Free Cash FlowFCF | -50.43M | -41.75M | -60.29M | -36.12M | -47.86M | -34.00M | -36.53M | -39.87M | -28.71M | -29.39M | -39.55M | -28.02M | -24.31M | -14.06M | -40.25M | -17.89M | -31.86M | -26.63M | -43.75M | -9.15M | ||||||||||||||||||||
| Net Cash FlowNCF | 23.03M | -33.12M | 19.29M | 34.67M | 71.88M | -57.41M | -18.10M | 6.14M | -51.17M | -4.32M | -6.45M | 108.54M | -113.54M | 40.64M | 16.96M | 29.83M | -83.67M | 2.01M | 7.47M | 3.70M |